Remission of adult acute lymphocytic leukaemia with Alemtuzumab [9]

Leukemia

Volumn 18, Issue 9, 2004, Pages 1557-1558

  Laporte, Jean Philippe ^a   Isnard, F ^a   Garderet, L ^a   Fouillard, L ^a   Gorin, Norbert Claude ^a  

^a CENTRE HOSPITALIER   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ALEMTUZUMAB; ATOVAQUONE; CYCLOPHOSPHAMIDE; DAUNORUBICIN; FLUCONAZOLE; GRANULOCYTE COLONY STIMULATING FACTOR; HEMOGLOBIN; ITRACONAZOLE; MAB CAMPATH; STEROID; VALACICLOVIR; VINCRISTINE; ANTINEOPLASTIC AGENT; CANCER ANTIBODY; MONOCLONAL ANTIBODY;

ACUTE LYMPHOCYTIC LEUKEMIA; ADULT; B CELL LEUKEMIA; BLAST CELL; BONE MARROW BIOPSY; CANCER COMBINATION CHEMOTHERAPY; CANCER RECURRENCE; CASE REPORT; CHROMOSOME ABERRATION; CHROMOSOME ANALYSIS; CHROMOSOME INVERSION; CLONAL VARIATION; CYTOPATHOLOGY; CYTOPENIA; ENCEPHALITIS; ERYTHRODERMA; HEMATOPOIESIS; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOPHENOTYPING; INFECTION COMPLICATION; LETTER; LEUKEMIA REMISSION; MALE; NEUTROPHIL; PANCYTOPENIA; PRIORITY JOURNAL; THROMBOCYTE COUNT; B LYMPHOCYTE; MIDDLE AGED; PATHOLOGY; REMISSION;

ANTIBODIES, MONOCLONAL; ANTIBODIES, NEOPLASM; ANTINEOPLASTIC AGENTS; B-LYMPHOCYTES; HUMANS; LEUKEMIA, B-CELL, ACUTE; MALE; MIDDLE AGED; REMISSION INDUCTION;

EID: 4444280672     PISSN: 08876924     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.leu.2403422     Document Type: Letter

References (6)

1. Hoelzer D, Gokbuget N, Ottmann O, Pui CH, Relling MV, Appelbaum FR et al. Acute lymphoblastic leukemia. Am Soc Haematol Educat Prog 2002, 162-192.
2. Hale G, Bright S, Chumbley G, Hoang T, Metcalf D, Munro AJ et al. Removal of T cells from bone marrow for transplantation: a monoclonal antilymphocyte antibody that fixes human complement. Blood 1983; 62: 873-882.
3. Zhang Z, Zhang M, Goldman CK, Ravetch JV, Waldmann TA. Effective therapy for a murine model of adult T-cell leukemia with the humanized anti-CD52 monoclonal antibody, Campath-1H. Cancer Res 2003; 63: 6453-6457.
4. Keating MJ, Cazin B, Coutre S, Birhiray R, Kovacsovics T, Langer W et al. Campath-1H treatment of T-cell prolymphocytic leukemia in patients for whom at least one prior chemotherapy regimen has failed. J Clin Onc 2002; 20: 205-213.
5. Dearden CE, Matutes E, Cazin B, Tjonnfjord GE, Parreira A, Nomdedeu B et al. High remission rate in T-cell prolymphocytic leukemia with CAMPATH-1H. Blood 2001; 98: 1721-1726.
6. Boissel N, Auclerc MF, Lheritier V, Perel Y, Thomas X, Leblanc T et al. Should adolescents with acute lymphoblastic leukemia be treated as old children or young adults? Comparison of the French FRALLE-93 and LALA-94 trials. J Clin Oncol 2003; 21: 760-761.